fda
-
Coronavirus
U.S. grapples with whether to modify COVID vaccine for fall
U.S. health authorities are facing a critical decision: whether to offer new COVID-19 booster shots this fall that are modified…
Read More » -
Health
FDA bans Juul e-cigarettes tied to teen vaping surge
WASHINGTON (AP) — U.S. health regulators have ordered Juul to pull its electronic cigarettes from the market, the latest blow…
Read More » -
Business
Many baby formula plants weren’t inspected because of COVID
WASHINGTON (AP) — U.S. regulators have historically inspected baby formula plants at least once a year, but they did not…
Read More » -
Coronavirus
FDA outside advisers recommend Pfizer, Moderna COVID vaccines for children under 5
WASHINGTON — Parents of children under 5 are one step closer to protecting them against COVID-19 after the U.S. Food…
Read More » -
Coronavirus
COVID vaccine for children under 5 could be available as soon as June 21
WASHINGTON — President Joe Biden’s administration is preparing to ship out to the states millions of COVID-19 vaccines for children…
Read More » -
Health
Baby formula industry was primed for disaster long before key factory closed down
The conditions that led to a shortage of baby formula were set in motion long before the February 2022 closure of the…
Read More » -
Health
U.S. House to vote on $28 million for FDA to relieve infant formula shortage
WASHINGTON — Democratic appropriators in the U.S. House have offered a $28 million emergency spending bill intended to address a…
Read More » -
Coronavirus
FDA clears COVID booster shot for healthy children ages 5-11
U.S. regulators have authorized a COVID-19 booster shot for healthy 5- to 11-year-olds, hoping an extra vaccine dose will enhance…
Read More » -
Health
Heartbeat-tracking technology raises patients’ and doctors’ worries
If someone’s heart skips a beat, tech companies want to let them know about it. Gadget firms — starting with…
Read More » -
Coronavirus
COVID vaccine for children under 5 delayed until at least April
WASHINGTON — A COVID-19 vaccine for young children will be delayed by at least two months as Pfizer and BioNTech…
Read More » -
Coronavirus
Some states forge ahead with COVID-19 booster shots for all adults
WASHINGTON — Federal health officials are expected as soon as Friday to expand access to COVID-19 booster shots to all…
Read More » -
Coronavirus
Pfizer asks regulators to OK promising COVID-19 pill
WASHINGTON (AP) — Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a…
Read More » -
Women
More turn to abortion pills by mail, with legality uncertain
TOPEKA, Kan. (AP) — Before her daughter’s birth, the woman had spent weeks in bed. Another difficult pregnancy would be…
Read More » -
Coronavirus
Pfizer asks FDA to OK COVID-19 booster shots for all adults
Pfizer asked U.S. regulators Tuesday to allow boosters of its COVID-19 vaccine for anyone 18 or older, a step that…
Read More » -
Coronavirus
FDA panel backs Pfizer’s low-dose COVID-19 vaccine for children
WASHINGTON (AP) — The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers…
Read More » -
Coronavirus
COVID-19 vaccines for ages 5 to 11 could be ready as soon as next week
WASHINGTON — The next wave of the massive COVID-19 vaccination campaign could begin as soon as next week, after federal regulators…
Read More » -
Coronavirus
CDC panel backs expanded COVID-19 booster rollout
WASHINGTON (AP) — Millions more Americans are closer to getting a COVID-19 booster as influential government advisers endorsed on Thursday…
Read More » -
Health
In quiet debut, Alzheimer’s drug finds questions, skepticism
The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more…
Read More » -
Coronavirus
FDA panel endorses booster shot for J&J COVID-19 vaccine
WASHINGTON (AP) — U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID-19 vaccine Friday, citing concern that Americans…
Read More » -
Coronavirus
Fauci says trick-or-treating this year is fine
WASHINGTON – The government’s top infectious diseases expert says families can feel safe trick-or-treating outdoors this year for Halloween as…
Read More » -
Coronavirus
Pfizer vaccine for children ages 5-11 may be available in November
WASHINGTON (AP) — Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19…
Read More » -
News
Medication abortion becomes latest GOP target
Medication abortion accounts for about 40% of all abortions in the U.S. The increasingly common method relies on pills rather…
Read More » -
Coronavirus
COVID-19 vaccine works in children ages 5-11, Pfizer reports
Pfizer said Monday that its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S.…
Read More » -
Coronavirus
FDA grants full approval to Pfizer’s COVID-19 shot, now known as ‘Comirnaty’
WASHINGTON — The U.S. has its first fully approved vaccine against COVID-19, with federal health officials announcing Monday the approval of Pfizer-BioNTech’s…
Read More » -
Coronavirus
COVID vaccines likely to get FDA’s full OK within weeks, Fauci hopes
WILMINGTON, Del. (AP) — The U.S. government’s top infectious disease expert, Dr. Anthony Fauci, said Sunday that he was hopeful…
Read More » -
Coronavirus
Pfizer to discuss vaccine booster with U.S. officials
WASHINGTON (AP) — Pfizer says it plans to meet with top U.S. health officials Monday to discuss the drugmaker’s request…
Read More » -
Health
FDA trims use of contentious Alzheimer’s drug amid backlash
WASHINGTON (AP) — A month after approving a controversial new Alzheimer’s drug, U.S. health regulators on signed off Thursday on…
Read More » -
News
Alzheimer’s drug stirs hope for patients, worry for doctors
In the weeks since a new Alzheimer’s drug was approved, hopeful patients have bombarded Dr. Alireza Atri with calls and…
Read More » -
Health
Half of U.S. cosmetics contain toxic chemicals, study finds
WASHINGTON (AP) — More than half the cosmetics sold in the United States and Canada are awash with a toxic…
Read More » -
Health
Medicare copays for new Alzheimer’s drug could reach $11,500
WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the…
Read More »
